ASIT biotech SA
Company profile
ASIT biotech SA specializes in the research and development of immunotherapeutic products for allergy treatment.
Source: Cofisem - Last Update: 19 Feb 2020
Key Executives
| Chief Executive Officer | Michel Baijot | ||||
| Chief Financial Officer | Frank Hazevoets | ||||
| Human Resources Director | Marie-Pierre Beaumont | ||||
| Source: Cofisem - Last Update: 04 Feb 2020 | |||||
Key figures
| Millenium | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Net sales | 4 | 5 | |||
| Income from ordinary activities | 4 | 8 | |||
| Operating income | -12,767 | -11,976 | -12,278 | -7,640 | -4,318 |
| Cost (net) of financial indebtedness | 6 | -54 | -71 | ||
| Equity-accounted companies' contribution to results | |||||
| Net profit from discontinued activities | |||||
| Net income | -14,321 | -11,986 | -12,339 | -7,715 | -4,429 |
| Net income (Group share) | -14,321 | -11,986 | -12,339 | -7,715 | -4,429 |
| Fiscal year end | 12.18 | 12.17 | 12.16 | 12.15 | 12.14 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | |||||
| Source: Cofisem - Last Update: 19 Feb 2020 | |||||